PT - JOURNAL ARTICLE AU - Gabriel G. Katul AU - Assaad Mrad AU - Sara Bonetti AU - Gabriele Manoli AU - Anthony J. Parolari TI - Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics AID - 10.1101/2020.04.10.20060954 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.10.20060954 4099 - http://medrxiv.org/content/early/2020/04/17/2020.04.10.20060954.short 4100 - http://medrxiv.org/content/early/2020/04/17/2020.04.10.20060954.full AB - The SIR (‘susceptible-infectious-recovered’) formulation is used to uncover the generic spread mechanisms observed by COVID-19 dynamics globally, especially in the early phases of infectious spread. During this early period, potential controls were not effectively put in place or enforced in many countries. Hence, the early phases of COVID-19 spread in countries where controls were weak offer a unique perspective on the ensemble-behavior of COVID-19 basic reproduction number Ro. The work here shows that there is global convergence (i.e. across many nations) to an uncontrolled Ro = 4.5 that describes the early time spread of COVID-19. This value is in agreement with independent estimates from other sources reviewed here and adds to the growing consensus that the early estimate of Ro = 2.2 adopted by the World Health Organization is low. A reconciliation between power-law and exponential growth predictions is also featured within the confines of the SIR formulation. Implications for evaluating potential control strategies from this uncontrolled Ro are briefly discussed in the context of the maximum possible infected fraction of the population (needed for assessing health care capacity) and mortality (especially in the USA given diverging projections). Model results indicate that if intervention measures still result in Ro > 2.7 within 49 days after first infection, intervention is unlikely to be effective in general for COVID-19. Current optimistic projections place mortality figures in the USA in the range of 100,000 fatalities. For fatalities to be confined to 100,000 requires a reduction in Ro from 4.5 to 2.7 within 17 days of first infection assuming a mortality rate of 3.4%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDaily confirmed COVID-19 infections in World countries are available at https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide (accessed on 08/04/2020). The dataset includes population estimates for each country as obtained from the 2018 United Nations census. Reported cases for UTLAs in the UK and provinces in Italy were obtained from https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases (accessed on 09/04/2020) and https://github.com/pcm-dpc/COVID-19 (accessed on 09/04/2020), respectively. Population counts for UTLAs and Italian provinces are available at https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland (accessed on 04/04/2020) and http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1 (accessed on 03/04/2020), respectively. https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases https://github.com/pcm-dpc/COVID-19 https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1